Markets:

Overview

News

Currencies

International

Treasuries

Organon & Co. Common Stock (NY:OGN)

7.765 +0.255 (+3.40%)

Streaming Delayed Price Updated: 11:29 AM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023 ↗

March 16, 2023

Via Benzinga

Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist

March 07, 2023

From Organon & Co.

Via Business Wire

Organon: Dividend Insights ↗

February 21, 2023

Via Benzinga

Why Shares of Organon Fell 15% Thursday ↗

February 16, 2023

The company reported fourth-quarter and year-end financials.

Via The Motley Fool

Earnings Scheduled For February 16, 2023 ↗

February 16, 2023

Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year...

Via Benzinga

Earnings Preview For Organon ↗

February 15, 2023

Via Benzinga

Organon Reports Better Than Expected Q3 Earnings ↗

November 03, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 14, 2023

Tuesday's morning session saw 84 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 16, 2023

Via Benzinga

Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 16, 2023

Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.

Via Benzinga

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2022

February 16, 2023

From Organon

Via Business Wire

Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023

February 06, 2023

From Organon & Co.

Via Business Wire

AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff ↗

January 31, 2023

Amgen launched its biosimilar knockoff on Tuesday at a steep discount.

Via Investor's Business Daily

'It's The Only China Stock I'd Buy': Cramer On This E-Commerce Stock ↗

January 26, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Alibaba Group Holding Limited (NYSE: BABA) is the only China stock he would buy.

Via Benzinga

Organon Stock Scores Market Leadership With Jump To 83 RS Rating ↗

January 17, 2023

Organon sees its Relative Strength Rating reach the 80-plus level.

Via Investor's Business Daily

Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy

January 05, 2023

From Organon & Co.

Via Business Wire

Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference

December 15, 2022

From Organon & Co.

Via Business Wire

Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary

December 12, 2022

From Organon & Co.

Via Business Wire

3 Dow Stocks to Take Seriously in 2023 ↗

November 29, 2022

The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings.

Via InvestorPlace

'FTX Users May Seek DeFi Alternatives,' Interview With Origin Protocol's Andra Nicolau ↗

November 28, 2022

In a risk-off environment where cryptocurrency has plummeted to a fraction of its previous valuation, it’s no secret raising capital in 2022 has become a challenge for startups and industry behemoths...

Via Benzinga

Organon To Present at the Piper Sandler 34th Annual Healthcare Conference

November 15, 2022

From Organon & Co.

Via Business Wire

10 Spin-Off Stocks That Pay Dividends ↗

November 07, 2022

10 spin-offs from recent years that now pay dividends after being separated from their parent companies.

Via Talk Markets

Recap: Organon Q3 Earnings ↗

November 03, 2022

Organon (NYSE:OGN) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Organon beat estimated earnings by...

Via Benzinga

Organon Reports Results for the Third Quarter Ended September 30, 2022

November 03, 2022

From Organon & Co.

Via Business Wire

Looking Into Organon's Recent Short Interest ↗

November 02, 2022

Organon's (NYSE:OGN) short percent of float has fallen 4.48% since its last report. The company recently reported that it has 5.78 million shares sold short, which is 2.56% of all regular shares that...

Via Benzinga

Origin Protocol Building DeFi & NFTs In The Bear: Interview With Co-Founder Joshua Fraser ↗

November 01, 2022

Blockchain startups raised an aggregate of billions of dollars through the bull market, but it’s no secret those days are at least temporarily halted. For most DeFi protocols and almost every NFT...

Via Benzinga

Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022

October 20, 2022

From Organon & Co.

Via Business Wire

Beat the Dow Jones With This Unstoppable Dividend Stock ↗

October 19, 2022

This pharmaceutical stock combines strong financials with an above-average dividend.

Via The Motley Fool

Roofstock onChain Sells 1st Real Estate Property On Ethereum, Powered by Origin Protocol NFTs and Teller DeFi ↗

October 18, 2022

Leading real estate investment platform Roofstock announced its 1st property sale via Ethereum’s blockchain, enabled by Roofstock onChain (ROC), its web3 subsidiary. Roofstock onChain is a real estate...

Via Benzinga

Jim Cramer Says People Are Betting Against Stock Up 84% This Year: It Could Be An 'Up Big, Down Big Situation' ↗

October 18, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Dice Therapeutics Inc (NASDAQ: DICE) as the company is "losing money hand over fist."

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.